INTRODUCTION
Obesity and associated disorders have increased significantly worldwide in the last decades and pose serious risks to the present and future health of humankind [Poirier et al., 2006] . Obesity alone can induce many additional health problems, including increased risk of insulin resistance, non--alcoholic fatty liver, atherosclerosis, degenerative disorders such as dementia, some immune-mediated disorders such as asthma, and certain cancers [Barness et al., 2007] .
Today, even well-structured calorie restriction and exercise programs that are supported by behavioral therapy may not be suffi cient to overwhelm obesity [Maguire & Haslam, 2010] . Thus, some potential herbs are being investigated and tested which may allow effective and reliable anti-obesity therapy with little side effect. Recently, it has been established that many herbal extracts can provide weight control by infl uencing lipid and carbohydrate metabolism. Some of these supplements, including Ephedra sinica, Paullinia cupana, Plantago psyllium, and Pausinystalia yohimbe, have harmful effects, whereas Garcinia cambogia and Ilex paraguariensis are considered relatively safe and merit further investigation [Pittler et al., 2005] . of potential compounds in the treatment of obesity [Bulló et al., 2007; Lim et al., 2013; BrahmaNaidu et al., 2014] . Thus, the aim of the present study was to evaluate the time-dependent effects of S. marianum on HFD-related metabolic disorders and weight increase. For evaluating therapeutic effects of S. marianum we planned to give the extract to rats for last 7 weeks, for evaluating its preventive effects we used the extract from the beginning of the study for 11 weeks. HFD-related biochemical parameters planned to be assessed included liver functions, serum lipid profi le, glucose, insulin, leptin and high sensitive C reactive protein (hsCRP) levels in plasma along with histopathological examination of the liver.
MATERIALS AND METHODS

Animal model and experimental design
This study was approved by Ethic Committee of Experimental Medical Research and Application Center of Selcuk University. It was performed on 40 male Sprague-Dawley rats weighing 80-100 g, which were 8 wk old at the beginning of experiment. All rats housed in stainless steel cages were placed in a room at 22-25°C. Rats were housed in 12:12 h light-dark cycle at a humidity of 50±5%. Rats were fed standard laboratory chow diet and water ad libitum for 1 week to stabilize their metabolic condition. After the 1-week adaptation, the animals were randomly divided into four groups:
-Group 1 (n=10): Animals were treated with a standard laboratory rat diet (SD) for 11 wk. -Group 2 (n=10): Animals were treated with HFD for 11 wk. -Group 3 (n=10): Animals were treated with HFD for 7 wk and then SME (200 mg/kg/day) added diet for the last 4 wk. -Group 4 (n=10) : Animals were treated with HFD and SME (200 mg/kg/day) for 11 wk. The rats had free access to food and water, and their food intake was measured daily while their body weight was measured twice a week. The composition of the diet for each experimental group is shown in Table 1 . Standard laboratory diet included 12% calories as fat with an energy density of 3.50 kcal/g and HFD contained 54% calories as fat with an energy density of 4.90 kcal/g [Terra et al., 2011] . The diets were given in the form of pellets. SME doses were determined at 200 mg/kg/day in the light of the studies by Crocenzi et al.
[2000], Chen et al. [2012] , and Tsai et al. [2008] .
At the end of the study, total food intake, body weight gain and food effi ciency ratio (body weight gain/total food intake x 100) were calculated.
Collection of serum and tissue samples
After 11 weeks of treatment, the rats were fasted for 12 h and then blood samples were collected through direct cardiac puncture under ketamine/xylazine anesthesia and rats were euthanized by cervical decapitation. Blood samples taken from the rats were centrifuged at 1,000×g for 10 min and serum samples were stored at -20°C until biochemical analysis. Livers were immediately excised, weighed, divided into smaller pieces and fi xed in 4% paraformaldehyde for histological analysis.
Measurement of body and organ weights
Body weight and length was measured twice a week during the feeding period. Body mass index (BMI) was determined in all animals as reported previously by other authors [Novelli et al., 2007] , using the formula: BMI=body weight (g)/ length 2 (cm 2 ), where "length" corresponds to the "nose-to--anus" length. At sacrifi ce, the weights of livers was measured.
Chemicals
SME was provided by Gaia Herbs Inc. (USA) and contained Silymarin of 80% and soy lecithin of 20% in addition to plant glycerin and cellulose.
Biochemical analyses of plasma
Serum triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma glutamyltransferase (GGT), high sensitive C reactive protein (hsCRP) and glucose levels were analyzed by photometric method using auto-analyzer kit according to methods defi ned by Rautela et Shaw et al. [1983] . Low-density lipoprotein cholesterol (LDL-C) levels were estimated according to Friedewald formula. All lipoprotein levels were recorded as mg/dL. Serum leptin levels were measured by using Biovendor ELISA kit, whereas serum insulin levels were analyzed by sandwich ELISA technique and Biovendor kit. HOMA-IR was calculated as: (fasting serum glucose × fasting serum insulin) / 22.5.
Histological evaluation of liver
Formaldehyde-fi xed liver tissues were embedded in paraffi n. Five-micrometer-thin sections were obtained and stained with hematoxylin and eosin (HE). Liver sections were observed by fl uorescence microscope. The steatosis/steatohepatitis was evaluated using a semi-quantitative scoring system [Wei et al., 2008] . The scoring was based on a chow diet group of animals for which if liver acini did not show lipid vacuoles, a score of zero was given (baseline). Acini having lipid vacuoles up to 33% (mainly macro vesicular type) were considered as score 1. Acini with 34-66% of lipid vacuoles were scored 2 while acini having over 66% of lipid vacuoles were ranked 3. 
RESULTS
Effect of SME on HFD-induced obesity
The effect of SME on growth characteristics is shown in Table 2 . Daily food intake per cage did not differ among groups. After 11 wk of treatment, rat body weights and BMI were signifi cantly higher in the HFD group compared with that in SD group (p<0.05). Treatment with SME for 11 wk decreased fi nal weight and fi nal BMI signifi cantly (p<0.05), but no signifi cant decrease was achieved when it was given during the last 4 wk compared with HFD group. Leptin levels were signifi cantly higher in HFD fed rats compared with SD group, and SME treatment for 4 wk and for 11 wk induced a signifi cant decrease in serum leptin levels (p<0.01) ( Table 3) . Also hsCRP levels were signifi cantly higher in HFD fed rats compared with SD group, and SME treatment for 4 wk and for 11 wk induced a signifi cant decrease in serum hsCRP levels (p<0.05) ( Table 3) .
Effect of SME on HFD-induced hyperlipidemia
As shown in Table 3 rats fed a diet enriched with lard fat for 11 wk developed hyperlipidemia. The levels of TC, TG and LDL-C in plasma were signifi cantly lower in the groups treated with SME for 4 and 11 wk compared with HFD group, demonstrating that dietary supplementation with SME improves lipid profi les.
Effect of SME on HFD-induced hepatopathy
Serum levels of ALT and GGT were signifi cantly higher in HFD group than in the SD group but SME treatment for 4 wk and for 11 wk induced a signifi cant decrease (p<0.01 and p<0.05, respectively). There was no signifi cant difference in serum AST levels (Table 3) . Rat liver sections were stained with hematoxylin & eosin (H & E) to assess fat accumulation. The fat deposition (lipid droplets) in stained sections of the HFD fed animals was of macro vesicular type. Based on the scoring method [Wei et al., 2008] , the HFD fed animals showed histopathological features of hepatic steatosis with a score of 2 indicating that over 33% of acini were occupied by lipid vacuoles compared to SD fed animals. There were clear, well delineated and the cytoplasmic vacuoles in the hepatocytes were of variable sizes. There were lipid vacuoles in the liver of HFD rats compared to the SD group and SME groups. It could be concluded then that the HFD animals displayed histopathological features of hepatic steatosis and SME supplementation improved it.
Effect of SME on HFD-induced insulin resistance
As shown in Table 3 serum insulin levels and HOMA-IR values were signifi cantly increased in HFD fed rats compared with SD group, and SME treatment for 4 wk and for 11 wk induced a signifi cant decrease in serum insulin levels (p˂0.001 and p˂0.01, respectively). In the results of this study, HFD feeding for 11 wk resulted in obesity, which was associated with increased body weight and BMI with development of hyperlipidemia. After the SME treatment for 4 wk, BMI and body weight did not alter signifi cantly while SME treatment for 11 wk signifi cantly decreased BMI and body weight. Increase in the infl ux of greater amounts of non-esterifi ed fatty acids to liver causes an increase in triacylglycerol level which may cause dyslipidemic changes in the obesity [Grundy et al., 2004] . It has been demonstrated that changes in lipid concentrations and lipoprotein fractions are associated with Results are the mean value ± standard deviation. Different letters in the same row indicate signifi cant differences, p˂0.05. 2 BMI, body mass index; SD, standard diet group; HFD, high-fat diet group; SME for 4 wk, high-fat diet + S. marianum extract for 4 wk group; SME for 11 wk, high-fat diet + S. marianum extract for 11 wk.
the increased risk for obesity-related metabolic conditions. It has been found that obesity is a signifi cant risk factor for the development of dyslipidemia [Montani et A number of studies were addressed to assess whether SME could effectively ameliorate lipoprotein profi le in rats [Haddad et al., 2011; Skottova et al., 2003; Gopalakrishnan et al., 2009] . In one of them, rats were fed with a high-fat liquid diet until they had fatty liver and then were treated with Silibin for 12 wk. The treatment decreased TC but not signifi cantly, besides it induced a signifi cant decrease in LDL-C levels [Haddad et al., 2011] . In other animal models the SME was also shown to be effective to reduce cholesterol at high cholesterol fed rats [Skottova et al., 2003 ] and hepatocellular carcinoma [Gopalakrishnan et al., 2009] . Also, silymarin reduced cholesterol absorption in rats fed on high cholesterol diet and caused signifi cant decreases in VLDL, cholesterol and TG in the liver [Sobolova et al., 2006] . Hence, the inhibition of cholesterol absorption by silymarin could be a mechanism contributing to the positive changes in plasma cholesterol lipoprotein profi le [Sobolova et al., 2006] .
In agreement to the above-mentioned studies, dyslipidemic changes manifested with increased levels of TG, TC and LDL-C were seen in the rats receiving HFD when compared to controls in the present study. Again, it was found that HDL-C levels were higher in the rats given SME than in the control groups. Interestingly, HDL-C level was increased only in rats receiving HFD. This indicates that different mechanisms may have role in the lipid metabolism of rats, which are currently unknown.
A HFD may increase the synthesis of fatty acids in the liver and the delivery of free fatty acids to the liver. It may also decrease β-oxidation of free fatty acids, which may, in turn, cause fat accumulation in the liver. Therefore, fat in hepatocytes results in cellular dysfunction and may damage the liver parenchyma. One of the most sensitive and dramatic indicators of hepatocyte injury is the release of intracellular enzymes such as transaminase in circulation. In our study, SME treatment has ameliorated ALT and GGT levels increased by HFD, which was in accordance with the data of Raja et al. [2007] . Moreover, there was no signifi cant difference between groups regarding AST levels. SME has also been shown to have favorable effects on other metabolic risk factors including fatty liver disease.
Although there are some researches that investigated the effects of S. marianum in HFD fed rats, these studies aimed to develop non-alcoholic fatty liver disease (NAFLD) not obesity so their dietary contents were different from ours. In one of them, Haddah et al.
[2011] used a dietary model that reproduced the clinical features of NASH in rats and SME induced amelioration in liver steatosis and infl ammation, decreased plasma levels of ALT, AST and tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β). Investigations show that SME exhibits excellent hepatoprotective property by restoring the hepatic marker enzymes and antioxidant property reversing the oxidant--antioxidant imbalance during CCL4, diethyl nitrosamine or methotrexate-induced oxidative stress in rats [Mao et al., 2012; El Mesallamy et al., 2011; Ghaffari et al., 2011] . Silymarin reduced high fructose diet-mediated increase in plasma pro-infl ammatory cytokines, C-reactive protein (CRP), interleukin-6 (IL-6), interferon-gamma (IFN-γ) and tumor necrosis factor (TNF) levels [Prakash et al., 2014] . It has been shown that hsCRP level which is one of the infl ammation markers, is increased in obesity, as it is an infl ammation--related process [Amasyali et al., 2010] . In a study by Galleti TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyltransferase; BMI, body mass index; HOMA IR, homeostasis model assessment insulin resistance; hsCRP, High sensitive C reactive protein; SD, standard diet group; HFD, high-fat diet group; SME for 4 wk, high fat diet + S. marianum extract for 4 wk group; SME for 11 wk, high-fat diet + S. marianum extract for 11 wk.
et al. [2007] , it was found that increased hsCRP levels were correlated to increase in leptin and HOMA-IR values independent of BMI and fat distribution in overweight individuals.
The results reported here confi rm that HFD does induce insulin resistance and mimics the metabolic characteristics of type 2 diabetes, with increase in blood glucose and body weight, as observed by study of Hamza et al. [2010] . Many studies have reported that HFD might be a good way to initiate the insulin resistance [Flanagan et al., 2008; Tanaka et al., 2007] which is the consequence of a number of defects including impaired insulin secretion by the pancreatic cell, resistance of peripheral tissues to the glucose utilizing effect of insulin and augmented hepatic glucose production [Shulman et al., 2000] . Decreased glycolysis impeded glycogenesis and increased gluconeogenesis are some of the changes of glucose metabolism in the diabetic liver [Baquer et al., 1998 ].
On the other hand, our results show that silymarin is able to ameliorate insulin resistance, evaluated by measuring glucose and insulin levels. Our observations of impaired HOMA--IR levels in HFD fed rats are consistent with previous reports [Falasca et [Abdul & Hussain, 2007] . Silymarin can improve pancreatic morphology and endocrine function, as well as the pancreatic activity of antioxidant enzymes and glutathione, in diabetic models [Soto et al., 2003 [Soto et al., , 2004 . These effects may decrease serum glucose and serum insulin. Silibinin, a widely used fl avonolignan from S. marianum, decreased the HOMA-IR level in obese diabetic mice [Volti et al., 2011] and methionine-choline defi cient diet fed mice [Salamone et al., 2012] . Additionally, the effect of SME on hepatic steatosis may contribute to its effects on insulin resistance [Prakash et al., 2014] . Hepatic steatosis is associated with insulin resistance in humans and studies in rodent models have shown that suppression of hepatic steatosis improved hepatic insulin sensitivity [Samuel et al., 2004] .
We have not seen a study that shows an association between serum leptin levels and S. marianum supplementation, so this is the fi rst study which demonstrates that S. marianum ameliorates increased leptin levels in rats. Leptin is produced by adipose tissue, and its level is closely correlated with the weight of adipose tissue [Friedman & Halaas, 1998 ]. Therefore, the decreased plasma leptin level associated with S. marianum supplementation may be attributable to the decrease of adipose tissue induced by S. marianum. Leptin might contribute to hepatic steatosis by promoting insulin resistance and also by altering insulin signaling in hepatocytes, so as to promote increased intracellular fatty acids [Sheth et al., 1997] . These data, together with those of serum insulin and leptin levels clearly show that SME was able to partially inhibit some effects of HFD.
Limitations, however, exist in this study: fi rstly, we did not evaluate fecal lipid so we were unable to determine if SME caused a decrease in fat absorption. Secondly, SME was orally-administered to experimental groups and the same amount of distilled water was orally given to control groups but disturbing every day could be a stress factor for rats. SME treatment may reverse the effects of a high-fat diet on BMI and this effect may be related to decreased fat absorption. Other possible mechanisms such as decreased fatty acid synthesis and increased fatty acid oxidation need further investigation. Finally, it will be important to clearly determine whether our observed effects occur in humans and whether SME consumption can be used as a tool to prevent the development of obesity and its comorbidities.
CONCLUSIONS
In summary, the present study has shown the potential protective action of SME on obesity-related diseases including cardiovascular disease and type 2 diabetes by ameliorating serum TC, LDL-C, HDL-C, TG, hsCRP, leptin and insulin concentrations. Results obtained in this study indicate the possibility of applying SME as a health-promoting food additive.
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